Name: Latest research reports of Dabur India Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dabur India Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	31 Jan 2025	Dabur	BOB Capital Markets Ltd. Reco Target	479.50	578.00	529.85 (-9.50%)	20.54	Hold	pdf post cache	Broker Report Dabur India (HOLD): Competition and inflation BOB Capital Markets Ltd. Competitive intensity has increased in the domestic business and Dabur is doing retailer discounts to maintain market share pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2025	Tata Consumer	BOB Capital Markets Ltd. Target	1109.90	1175.00	1024.65 (8.32%)	Target met	Buy	pdf post cache	Broker Report Tata Consumer Products (BUY): Staying rational BOB Capital Markets Ltd. Tea inflation recovery prospects have improved as higher pricing has come through earlier than expected pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	IDFC First Bank	BOB Capital Markets Ltd. Target	67.98	75.00	56.73 (19.83%)	10.33	Buy	pdf post cache	Broker Report IDFC First Bank (BUY): Subdued performance, elevated provisioning BOB Capital Markets Ltd. Earnings lower on account of higher slippages, moderate loan book growth pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	ICICI Bank	BOB Capital Markets Ltd. Reco Target	1458.90	1415.00	1227.95 (18.81%)	Target met	Buy	pdf post cache	Broker Report ICICI Bank (BUY): Continue to demonstrate stable performance BOB Capital Markets Ltd. PAT growth of 15% YoY aided by stable credit cost and PPOP growth of 15% YoY pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	Laurus Labs	BOB Capital Markets Ltd. Target	610.80	488.00	534.65 (14.24%)	20.10	Sell	pdf post cache	Broker Report Laurus Labs (SELL): Margin guidance shifted from 20% to closer to 20% for FY25E BOB Capital Markets Ltd. Revenue/EBITDA/PAT exceeded our estimates by 10.5%/46.6%/227%. EBITDA margin surpassed our estimate by 500bps pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2025	DCB Bank	BOB Capital Markets Ltd. Target	147.00	140.00	117.79 (24.80%)	Target met	Buy	pdf post cache	Broker Report DCB Bank (BUY): Solid performance BOB Capital Markets Ltd. Robust business growth with strong advances growth above our estimates pdf Copy Link Share on Share on Share on Share on Alert
	25 Jan 2025	MphasiS	BOB Capital Markets Ltd. Reco Target	2541.70	2651.00	3009.30 (-15.54%)	Target met	Sell	pdf post cache	Broker Report Mphasis (SELL): Not a steady performing Tier-2 player yet BOB Capital Markets Ltd. 3QFY25 has yet again proven the volatility in Mphasis's business compared to its Tier-2 peers like Persistent & Coforge pdf Copy Link Share on Share on Share on Share on Alert
	24 Jan 2025	Dr. Reddy's Labs	BOB Capital Markets Ltd.	1244.50	1427.00	1224.40 (1.64%)	14.66	Hold	pdf post cache	Broker Report Dr Reddys Labs (HOLD): NRT business to require huge marketing spend BOB Capital Markets Ltd. North America sales missed our estimates and reported US$ 395mn in 3QFY25 vs US$ 445mn in 2QFY25 impacted by gRevlimid pdf Copy Link Share on Share on Share on Share on Alert
	24 Jan 2025	Coforge	BOB Capital Markets Ltd. Reco Target	8478.50	7072.00	9234.60 (-8.19%)	Target met	Sell	pdf post cache	Broker Report Coforge (SELL): On the journey to becoming a Tier-1 BOB Capital Markets Ltd. 3QFY25 was blockbuster quarter 8.4% growth QoQ in CC terms (our estimate-2.8%. Belied seasonality) pdf Copy Link Share on Share on Share on Share on Alert
	24 Jan 2025	Zensar Technologies	BOB Capital Markets Ltd.	835.00	700.00	831.75 (0.39%)	Target met	Sell	pdf post cache	Broker Report Zensar Technologies (SELL): Headed towards double digit growth in FY26 BOB Capital Markets Ltd. Delivered better-than-expected revenue and margin. After a mid-single digit FY25, revenue growth in double digits in FY26 likely pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Dabur India (HOLD): Competition and inflation

Tata Consumer Products (BUY): Staying rational

IDFC First Bank (BUY): Subdued performance, elevated provisioning

ICICI Bank (BUY): Continue to demonstrate stable performance

Laurus Labs (SELL): Margin guidance shifted from 20% to closer to 20% for FY25E

DCB Bank (BUY): Solid performance

Mphasis (SELL): Not a steady performing Tier-2 player yet

Dr Reddys Labs (HOLD): NRT business to require huge marketing spend

Coforge (SELL): On the journey to becoming a Tier-1

Zensar Technologies (SELL): Headed towards double digit growth in FY26

Advisor Screeners